Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 182.11 billion as of March 9, 2026. Its market cap has decreased by -20.80% in one year.

Market Cap

182.11B

Enterprise Value

144.06B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

7,830.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 182.11B, an increase of 13.65%. That is a compound annual growth rate of 2.37%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	182.11B	-21.62%
Dec 30, 2025	232.34B	-3.12%
Dec 30, 2024	239.82B	-53.54%
Dec 28, 2023	516.20B	-0.71%
Dec 29, 2022	519.87B	-21.31%
Dec 30, 2021	660.68B	-73.75%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
iNtRON Biotechnology	197.72B
Macrogen	185.06B
ENCell	177.52B
MedPacto	174.46B
Genexine	231.04B
EASY BIO,Inc.	233.89B
HLB Therapeutics	241.80B
Helixmith	294.70B

Market Cap Rankings